These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2091887)

  • 1. Pharmacokinetics of eltoprazine in the dog.
    Lammers R; van Harten J
    Drug Metabol Drug Interact; 1990; 8(1-2):141-8. PubMed ID: 2091887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of eltoprazine in healthy subjects.
    van Harten J; Mathlener IS; Raghoebar M
    Drug Metabol Drug Interact; 1990; 8(1-2):149-58. PubMed ID: 2091888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of eltoprazine in healthy male subjects after single dose oral and intravenous administration.
    Raghoebar M; Mak M; Cournot A; Pistorius MC; Van Harten J; Roseboom H
    Br J Clin Pharmacol; 1990 Dec; 30(6):879-83. PubMed ID: 2288834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-proportionality of eltoprazine. Pharmacokinetics of single oral doses in healthy subjects.
    de Vries MH; de Koning P; Floot HL; Grahnén A; Eckernäs SA; Raghoebar M; Dahlström B; Ekman L
    Eur J Clin Pharmacol; 1991; 41(5):485-8. PubMed ID: 1761079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs.
    Supko JG; Garcia-Carbonero R; Puchalski TA; Malspeis L
    Cancer Chemother Pharmacol; 2001 Sep; 48(3):202-8. PubMed ID: 11592341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man.
    Walker DK; Ackland MJ; James GC; Muirhead GJ; Rance DJ; Wastall P; Wright PA
    Xenobiotica; 1999 Mar; 29(3):297-310. PubMed ID: 10219969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability and disposition kinetics of HI-6 in Beagle dogs.
    Baggot JD; Buckpitt A; Johnson D; Brennan P; Chung H
    Biopharm Drug Dispos; 1993 Mar; 14(2):93-105. PubMed ID: 8453028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and metabolism of a selective PDE5 inhibitor (UK-343,664) in rat and dog.
    Walker DK; Beaumont KC; Comby P; Evans KM; Gedge JI; Halliday RC; Roffey SJ; Wright PA
    Xenobiotica; 2001; 31(8-9):651-64. PubMed ID: 11569531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous pharmacokinetics and absolute oral bioavailability of dolasetron in healthy volunteers: part 1.
    Dimmitt DC; Choo YS; Martin LA; Arumugham T; Hahne WF; Weir SJ
    Biopharm Drug Dispos; 1999 Jan; 20(1):29-39. PubMed ID: 10086835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of the anti-leishmanian agent WR 6026 in dogs.
    Taylor T; Hawkins DR; Morris GR; Chung H
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():136-9. PubMed ID: 1820868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of ibafloxacin following intravenous and oral administration to healthy Beagle dogs.
    Coulet M; Van Borssum Waalkes M; Leeuwenkamp OR; Cox P; Lohuis J
    J Vet Pharmacol Ther; 2002 Apr; 25(2):89-97. PubMed ID: 12000528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and bioavailability of spectinomycin after i.v., i.m., s.c. and oral administration in broiler chickens.
    Abu-Basha EA; Gehring R; Albwa'neh SJ
    J Vet Pharmacol Ther; 2007 Apr; 30(2):139-44. PubMed ID: 17348899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and bioavailability of topiramate in the beagle dog.
    Streeter AJ; Stahle PL; Holland ML; Pritchard JF; Takacs AR
    Drug Metab Dispos; 1995 Jan; 23(1):90-3. PubMed ID: 7720530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
    Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single dose pharmacokinetics and absolute bioavailability of mirabegron, a β₃-adrenoceptor agonist for treatment of overactive bladder.
    Eltink C; Lee J; Schaddelee M; Zhang W; Kerbusch V; Meijer J; van Marle S; Grunenberg N; Kowalski D; Drogendijk T; Moy S; Iitsuka H; van Gelderen M; Matsushima H; Sawamoto T
    Int J Clin Pharmacol Ther; 2012 Nov; 50(11):838-50. PubMed ID: 22943933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study of salvianolic acid A in beagle dog after oral administration by a liquid chromatography-mass spectrometry method: a study on bioavailability and dose proportionality.
    Sun J; Zhang L; Song J; Tian S; Huang C; Feng Z; Lv Y; Du G
    J Ethnopharmacol; 2013 Jul; 148(2):617-23. PubMed ID: 23707334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute bioavailability, pharmacokinetics, and urinary excretion of the novel antimigraine agent almotriptan in healthy male volunteers.
    Jansat JM; Costa J; Salvà P; Fernandez FJ; Martinez-Tobed A
    J Clin Pharmacol; 2002 Dec; 42(12):1303-10. PubMed ID: 12463724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute bioavailability study in the dog with Visacor, a new cardioselective beta blocking drug with intrinsic sympathomimetic activity.
    McAinsh J; Smith RP; Ferguson RA
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):129-39. PubMed ID: 6146530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.